NCT01245426 - A Study in Asthmatics to Determine the Efficacy and Dose Response of Repeat Doses of GW870086X on Forced Expiratory Volume in 1 Second (FEV1) | Biotech Hunter

Enrollment

136

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

July 31, 2011

Study Completion Date

August 31, 2011

Conditions

Asthma

Interventions

DRUG

GW870086 2mg

oral inhalation

DRUG

GW870086 4mg

oral inhalation

DRUG

GW870086 Placebo

oral inhalation

DRUG

GW870086 1mg

oral inhalation

DRUG

GW870086 3mg

oral inhalation

Trial Locations (11)

1612

GSK Investigational Site, Sofia

6045

GSK Investigational Site, Newton Park, Port Elizabeth

6529

GSK Investigational Site, George

9301

GSK Investigational Site, Bloemfontein

10969

GSK Investigational Site, Berlin

14050

GSK Investigational Site, Berlin

20354

GSK Investigational Site, Hamburg

23552

GSK Investigational Site, Lübeck

30625

GSK Investigational Site, Hanover

39112

GSK Investigational Site, Magdeburg

60596

GSK Investigational Site, Frankfurt am Main